Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-17

Clinical Trial Update: The Effect of Metformin on Reducing Lupus Flares [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether metformin reduces disease flares in systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: RenJi Hospital | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: COMPLETED